MTOR and neoplasm: Intriguingly, the phosphoinositide 3-kinase/mTOR (PI3K/mTOR) signaling pathway–related gene expression profile was altered in tumor-infiltrating SENP7-deficient CD8+ T cells (Figure 4A).